Oracle Children’s Study (19th September 2008)
The Chief Medical Officer (CMO), Chief Nursing Officer (CNO) and the Chief Pharmaceutical Office (CPHO) issued letters regarding a report on the Oracle Children Study, which was published online today by The Lancet. This is a 7-year follow-up study of a randomised controlled trial of the use of erythromycin and/or co- amoxiclav for women presenting in premature labour.
PL/CMO/2008/6
PL/CNO/2008/6
PL/CPHO/2008/4
The Chief Medical Officer (CMO), Chief Nursing Officer (CNO) and the Chief Pharmaceutical Office (CPHO) issued letters regarding a report on the Oracle Children Study, which was published online today by The Lancet. This is a 7-year follow-up study of a randomised controlled trial of the use of erythromycin and/or co- amoxiclav for women presenting in premature labour.
PL/CMO/2008/6
PL/CNO/2008/6
PL/CPHO/2008/4
No comments:
Post a Comment